C4 Therapeutics, Inc. (CCCC)
2.43
-0.04
(-1.62%)
USD |
NASDAQ |
Dec 15, 16:00
2.41
-0.02
(-0.82%)
Pre-Market: 09:13
C4 Therapeutics Shareholders Equity (Quarterly): 154.41M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Biogen, Inc. | 18.21B |
| Amicus Therapeutics, Inc. | 230.42M |
| GT Biopharma, Inc. | 3.00M |
| Nurix Therapeutics, Inc. | 372.25M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 265.49M |
| Total Liabilities (Quarterly) | 111.08M |
| Debt to Equity Ratio | 0.3981 |
| Current Ratio | 5.755 |
| Net Debt Paydown Yield | 0.84% |